Tag Archives: the-development

Response Genetics to Present at the 22nd Annual UBS Global Healthcare Services Conference

Response Genetics, Inc. , a company focused on the development and sale of molecular diagnostic tests for cancer, announced today that Thomas Bologna, CEO and Chairma Continue reading

Posted in Genetics | Tagged , , , , , , , , , , , , | Comments Off

Study explores possible 'safe and effective' anti-cancer therapy

Betts, a professor in Schulich's Department of Physiology and Pharmacology, says this better understanding of cancer cell growth may help in the development of anti-cancer drugs that specifically target telomeres. “Like the plastic aglets used at the end of our shoelaces to prevent fraying, telomeres protect the ends of our chromosomes,” explains Betts. “Most human cells lose a bit of each telomere every time it divides triggering cell death or arrest when a critically short telomere length is reached Continue reading

Posted in Cell Medicine | Tagged , , , , , , , , | Comments Off

Dr. Ramaswamy on Targeting Dormant Cancer Cells – Video


01-02-2012 14:59 Sridhar Ramaswamy, MD, Massachusetts General Hospital Cancer Center, Assistant Professor of Medicine, Harvard Medical School, Harvard Stem Cell Institute, discusses targeting dormant cancer cells and the possible role that they play in the development of drug resistance. Dormant cells appear in most patients with tumors. These cells are not rapidly proliferating and remain largely inactive. Continue reading

Posted in Cell Medicine | Tagged , , , , , , , , , , , , , , | Comments Off

Nanomedicine Panel BioEurope 2011 – clinical development – Video


13-12-2011 10:03 Nanomedicine: The Path to Personalized Medicine? Is the development of a nanoparticle different from a classic drug? Continue reading

Posted in Nano medicine | Tagged , , , , , , | Comments Off

Craig Venter: Understanding Our Genes – A Step to Personalized Medicine | CIRM Spotlight on Genomics – Video


24-01-2012 10:25 On January 17th, 2012, the CIRM Governing Board heard from scientists and a patient about the essential role of genomics in the development of stem cell based therapies. Continue reading

Posted in Cell Medicine | Tagged , , , , , , , , , , | Comments Off

Stem cell-derived neurons may help find cause of Alzheimer's

London, Jan 26 (ANI): Scientists have made a breakthrough in understanding the causes of Alzheimer's disease, which could potentially lead to the development of new drugs to treat it. Continue reading

Posted in Cell Medicine | Tagged , , , , , , , , , , | Comments Off

Genetic screens bring new hope for tackling sleeping sickness

Research led by scientists at the London School of Hygiene & Tropical Medicine has exploited a revolutionary genetic technique to discover how human African Trypanosomiasis drugs target the parasite which causes the disease. The new knowledge could help lead to the development of better treatments for the tens of thousands of people in sub-Saharan Africa who are affected each year. Continue reading

Posted in Genetic Medicine | Tagged , , , , , , , , , , , , , | Comments Off

Genetic technique brings new hope for better treatments for sleeping sickness

Research led by scientists at the London School of Hygiene & Tropical Medicine has exploited a revolutionary genetic technique to discover how human African Trypanosomiasis (HAT) drugs target the parasite which causes the disease. Continue reading

Posted in Genetic Medicine | Tagged , , , , , , , , | Comments Off

Response Genetics, Inc. to Offer FDA-Approved ALK Test for metastatic NSCLC

Response Genetics Inc. , a company focused on the development and sale of molecular diagnostic tests for cancer, today announced the addition of new anaplastic lymphoma kinase testing capabilities. Continue reading

Posted in Genetics | Tagged , , , , , , , , , , , | Comments Off

SANUWAVE Technology Shown to Proliferate Adult Stem Cells

ALPHARETTA, Ga.–(BUSINESS WIRE)–SANUWAVE Health, Inc. (OTCBB: SNWV), an emerging medical technology company focused on the development and commercialization of noninvasive, biological response activating devices in regenerative medicine, today announced the publication of peer-reviewed, preclinical data that demonstrate the ability of the Company’s extracorporeal shock wave technology (ESWT … Continue reading

Posted in Regenerative Medicine | Tagged , , , , , , , , , , , , , , | Comments Off